Arena Pharmaceuticals Inc organizacji EBITDA margin
Jaka jest wartość EBITDA margin organizacji Arena Pharmaceuticals Inc?
Wartość EBITDA margin organizacji Arena Pharmaceuticals Inc to -1,015,500.00%
Jaka jest definicja EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin firm w Health Care sektor na NASDAQ w porównaniu do Arena Pharmaceuticals Inc
Czym się zajmuję organizacja Arena Pharmaceuticals Inc?
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
Firmy z ebitda margin podobne do Arena Pharmaceuticals Inc
- Wartość EBITDA margin organizacji AZ Leasing SPA to -1,251,900.00%
- Wartość EBITDA margin organizacji Pacgold to -1,113,809.64%
- Wartość EBITDA margin organizacji Altan Nevada Minerals to -1,103,594.44%
- Wartość EBITDA margin organizacji MetalsTech to -1,065,856.86%
- Wartość EBITDA margin organizacji Avalon Advanced Materials to -1,039,102.87%
- Wartość EBITDA margin organizacji Raiden Resources to -1,035,879.18%
- Wartość EBITDA margin organizacji Arena Pharmaceuticals Inc to -1,015,500.00%
- Wartość EBITDA margin organizacji Talon Metals to -1,008,048.83%
- Wartość EBITDA margin organizacji Resource Base Ltd to -931,507.14%
- Wartość EBITDA margin organizacji Zinc of Ireland NL to -893,008.00%
- Wartość EBITDA margin organizacji Resource Mining to -869,061.90%
- Wartość EBITDA margin organizacji BelaraRox Ltd to -858,466.20%
- Wartość EBITDA margin organizacji GORE German Office Real Estate AG to -854,792.73%